Clinical Trials Directory

Trials / Completed

CompletedNCT02766244

Indocyanine Green (ICG) and SPY Imaging for Assessment of Burn Healing

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
3 (actual)
Sponsor
Texas Tech University Health Sciences Center · Academic / Other
Sex
All
Age
18 Years – 89 Years
Healthy volunteers
Not accepted

Summary

Three patients were recruited for assessment of ICG fluorescence in burns.

Detailed description

The early determination of healing potential in indeterminate thickness burns may be difficult to establish by visual inspection alone, even for experienced burn practitioners. This case series explores the use of indocyanine green (ICG) fluorescence using portable bedside assessment as a potential tool for early determination of burn depth. Three subjects with indeterminate thickness burns had daily perfusion assessment using ICG fluorescence assessment using the SPY machine (SPY®, Lifecell Corp., NJ, USA) in addition to standard burn care. The fluorescence was quantified as a percentage of the perfusion of intact skin, and areas of hypo and hyper-perfusion were indicated. The burn surgeon, blinded to the ICG results, made a clinical determination of the need for skin grafting or discharge. The perfusion in areas of differing depth of burn were compared over the entire study period to determine both the magnitude of difference, and the point in the time course of healing when these changes became evident.

Conditions

Interventions

TypeNameDescription
DEVICEICG/SPYindocyanine green fluorescence imaging
DRUGAntibiotic OintmentAntibiotic ointment

Timeline

Start date
2014-01-01
Primary completion
2014-07-01
Completion
2014-07-01
First posted
2016-05-09
Last updated
2016-06-17
Results posted
2016-06-17

Source: ClinicalTrials.gov record NCT02766244. Inclusion in this directory is not an endorsement.